Search

Search Constraints

You searched for: Author/Creator Shiffman, Mitchell

Search Results

1. Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. Issue 2 (26th May 2015)

2. Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir +/‐Ribavirin in Patients Receiving Concomitant Acid‐Reducing Agents in Phase 3 Trials: 2019. (October 2015)

3. Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Issue 2 (26th November 2018)

5. IDDF2019-ABS-0131 Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials. (June 2019)

6. IDDF2019-ABS-0133 Routinely available noninvasive tests discriminate advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib. (June 2019)

7. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

10. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)